BioSpace News Archive

Nobelpharma America, LLC, a pharmaceutical and medical device company headquartered in Bethesda, Maryland, today announced its attendance at the American Epilepsy Society 2021 Annual Meeting, December 3-7, 2021.

Alcresta Therapeutics, Inc. announced the appointment of Chris Parrish as its Chief Operations Officer (COO) effective November 29, 2021.

Funding will Advance Immusoft’s Immune System Programming Platform.

Modular Medical, Inc. today announced the expansion of its Board of Directors with the appointment of two independent directors, Steven G. Felsher and Philip B. Sheibley.

Valencia Technologies, a privately held company, today announced the expansion of its leadership team with the appointments of Jerry Schloffman as Chief Commercial Officer, Jim Crines as Interim Chief Financial Officer, Arthur Rascon as Senior Vice President of Operations, and Ann Decker as Vice President of Reimbursement.

RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) (“RegeneRx”), a clinical-stage drug development company focused on tissue protection, repair and regeneration), today announced that its U.S. joint venture, ReGenTree LLC, has submitted a letter to the U.S. FDA requesting a pre-BLA meeting pursuant to RGN-259.

LensGen, Inc. announced today that it has received approval for an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a pivotal study of the company’s Juvene intraocular lens (IOL) for patients with cataracts.

Kineta, Inc., a clinical stage biotechnology company focused on the development of novel immunotherapies in oncology, announced today a presentation describing the Phase 1/2 trial design supporting KVA12.1 for the potential treatment of difficult-to-treat solid tumors at the Society for Immunotherapy of Cancer (SITC) 36th Anniversary Annual Meeting.

Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced the publication of a Teaser titled “Abivertinib – a Franchise Oral Therapeutic for Cancer, COVID-19 and Autoimmune Diseases” (“Abivertinib Teaser”).

ClariPi, a leading AI medical imaging company, is presenting its AI-powered low-dose CT denoising solution, ClariCT.AI along with new innovative AI imaging solutions at RSNA 2021.